SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
230 hedge funds and large institutions have $640M invested in Sorrento Therapeutics, Inc. in 2021 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 71 increasing their positions, 67 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 218 → 230 (+12)
6% more repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 67
Holders
230
Holding in Top 10
2
Calls
$75.7M
Puts
$39.3M
Top Buyers
| 1 | +$18.9M | |
| 2 | +$13.1M | |
| 3 | +$11.2M | |
| 4 |
JP Morgan Chase
New York
|
+$10.4M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$5.51M |
Top Sellers
| 1 | -$30.5M | |
| 2 | -$18.5M | |
| 3 | -$13.2M | |
| 4 |
Morgan Stanley
New York
|
-$12.1M |
| 5 |
Jane Street
New York
|
-$9.23M |